2009
DOI: 10.1016/j.ijpharm.2009.07.025
|View full text |Cite
|
Sign up to set email alerts
|

Formation of ion pairing as an alternative to improve encapsulation and stability and to reduce skin irritation of retinoic acid loaded in solid lipid nanoparticles

Abstract: This work aims to investigate the influence of the formation of ion pairing between all-trans retinoic acid (RA) and a lipophilic amine (stearylamine; STE) on the drug encapsulation efficiency (EE) and stability of solid lipid nanoparticles (SLNs). The SLNs were characterized for EE and size. The EE and particle size were significantly improved and reduced, respectively, when the surfactant or co-surfactant concentration increased. However, while the formulation without STE allowed only 13% of RA encapsulation… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

6
63
0
2

Year Published

2012
2012
2021
2021

Publication Types

Select...
3
3
1

Relationship

0
7

Authors

Journals

citations
Cited by 107 publications
(71 citation statements)
references
References 27 publications
6
63
0
2
Order By: Relevance
“…19 Considering the intended use of SLNs (intravenous administration), Tween 80™ was selected as surfactant. Briefly (batch 20 mL), the oily phase, composed of Compritol (400 mg), cholesterol (40 mg), Tween 80™ (300 mg), RA (10 mg), and the aqueous phase were heated separately to 85°C.…”
Section: Preparation Of Slnsmentioning
confidence: 99%
See 3 more Smart Citations
“…19 Considering the intended use of SLNs (intravenous administration), Tween 80™ was selected as surfactant. Briefly (batch 20 mL), the oily phase, composed of Compritol (400 mg), cholesterol (40 mg), Tween 80™ (300 mg), RA (10 mg), and the aqueous phase were heated separately to 85°C.…”
Section: Preparation Of Slnsmentioning
confidence: 99%
“…The data reported were particle size, evaluated as the intensity obtained from three repeat measurements, and the polydispersity index. 19 …”
Section: Particle Size Analysismentioning
confidence: 99%
See 2 more Smart Citations
“…SLN's have been investigated for parenteral drug delivery and have successfully been demonstrated to possess good pharmacokinetics and tissue distribution characteristics when used for drugs such as doxorubicin and tobramycin (Bargoni et al 2001;Zara et al 2002). SLN based topical formulations have also been developed for cosmetic applications, and some products are already being marketed commercially (Castro, et al 2009;Müller et al 2002). Notably, SLN's have been investigated for oral drug delivery and have been shown to exhibit good release characteristics and systemic bioavailability of the encapsulated drugs (Demirel et al 2001;Yang, et al 1999).…”
Section: Introductionmentioning
confidence: 99%